Masatomo Miura

Title: Masatomo Miura: Innovator in Cancer Detection

Introduction

Masatomo Miura is a notable inventor based in Akita, Japan. He has made significant contributions to the field of cancer detection, particularly in the area of lymph node metastasis. With a total of 2 patents, his work is recognized for its clinical significance and potential impact on treatment strategies.

Latest Patents

Miura's latest patents include a method for determining lymph node metastasis in cancer or the risk thereof, along with a rapid determination kit for the same. The objective of this invention is to provide a method and means of rapidly and reliably detecting lymph node metastasis in cancer or the risk of lymph node metastasis. Specifically, the invention identifies a certain genetic polymorphism of the human CRP gene, which is clinically significant in determining treatment strategies. This effective prediction and determination regarding lymph node metastasis is crucial, as it plays an important role in cancer progression.

Career Highlights

Throughout his career, Miura has worked with esteemed institutions such as Akita University and Arkay, Inc. His experience in these organizations has contributed to his expertise in cancer research and innovation.

Collaborations

Some of Miura's notable coworkers include Satoru Motoyama and Junichi Ogawa. Their collaborative efforts have further advanced the research and development of cancer detection methods.

Conclusion

Masatomo Miura's innovative work in cancer detection exemplifies the importance of research in improving treatment strategies. His contributions are vital in the ongoing fight against cancer, particularly in understanding lymph node metastasis.